Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Efficacy and Safety of Daclizumab High Yield Process Versus Interferon β 1a in Patients With Relapsing-Remitting Multiple Sclerosis ((DECIDE))
Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis.
A silver lining of neuroinflammation: Beneficial effects on myelination.
A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
Autoimmune myelopathies.
The role of pre-morbid intelligence and cognitive reserve in predicting cognitive efficiency in a sample of Italian elderly.
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Compliance to fingolimod and other disease modifying treatments in multiple sclerosis patients, a retrospective cohort study.
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.
A study to evaluate the effect of ultrasound treatment on nodules in multiple sclerosis patients.
Some recent advances in multiple sclerosis.
Dimethyl fumarate protection against collagen II degradation.
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica.
Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function.
A Multiple-Dose, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray.
Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta.
Preclinical studies of sex differences: a clinical perspective.
Oligodendrocyte development and myelination in GFP-transgenic zebrafish.
Association of common mitochondrial DNA variants with multiple sclerosis and systemic lupus erythematosus.
Morphogenesis of the demyelinating lesions in Baló's concentric sclerosis.
Magnetic resonance imaging outcomes from a phase III trial of teriflunomide.
Disease-modifying drugs for multiple sclerosis in pregnancy: A systematic review.
Laquinimod in Relapsing-Remitting Multiple Sclerosis
Subclinical primary retinal pathology in neuromyelitis optica spectrum disorder.

Pages